Bharat Biotech Completes Trials For Intranasal Covid Vax – BBV154 ...Middle East

New Delhi:  Hyderabad-based vaccine manufacturer Bharat Biotech on Monday said it has completed the clinical development for phase 3 trials and booster doses for India’s first intranasal Covid vaccine — BBV154. The vaccine manufacturer said that BBV154 (intra nasal vaccine) has proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials. The […] The post Bharat Biotech Completes Trials For Intranasal Covid Vax – BBV154 appeared first on Ommcom News.

Hence then, the article about bharat biotech completes trials for intranasal covid vax bbv154 was published today ( Tuesday 16/08/2022 - 06:08 AM ) and is available on Ommcom News ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Bharat Biotech Completes Trials For Intranasal Covid Vax – BBV154 )

Also on site :

• What the US strike in Venezuela means for gas prices and the largest proven oil reserve on the planet
• Ukraine-Russia war latest: Zelensky and Starmer discuss how to spend billions seized from Abramovich after Chelsea sale
• State of emergency declared: Venezuela mobilizes following US airstrikes